RegCell lands $44M Series A to take Nobel-winning Tregs into clinic
For nearly 50 years, Shimon Sakaguchi has been studying and working on regulatory T cells, figuring out how the immune system "governs itself." Now, the Nobel laureate's decade-old biotech RegCell is gearing up for clinical ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.